Campbell BA - Search Results

1

Mycosis fungoides and Sézary syndrome: Australian clinical practice statement.

Bhabha FK, McCormack C, Wells J, Campbell BA, Newland K, Lade S, Buelens O, Joske D, Shortt J, Mapp S, Radeski D, Hertzberg M, Khot A, Van Der Weyden C, Khoo C, Hawkes E, Prince HM. Bhabha FK, et al. Among authors: campbell ba. Australas J Dermatol. 2021 Feb;62(1):e8-e18. doi: 10.1111/ajd.13467. Epub 2020 Dec 26. Australas J Dermatol. 2021. PMID: 33368169 Review.

2

Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy.

Fox LC, Yannakou CK, Ryland G, Lade S, Dickinson M, Campbell BA, Prince HM. Fox LC, et al. Among authors: campbell ba. Int J Mol Sci. 2018 Jun 13;19(6):1758. doi: 10.3390/ijms19061758. Int J Mol Sci. 2018. PMID: 29899297 Free PMC article.

3

Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary syndrome.

Gao C, McCormack C, van der Weyden C, Goh MS, Campbell BA, Twigger R, Buelens O, Harrison SJ, Khoo C, Lade S, Prince HM. Gao C, et al. Among authors: campbell ba. Blood. 2019 Oct 17;134(16):1346-1350. doi: 10.1182/blood.2019000765. Blood. 2019. PMID: 31467061 Free article.

4

A comparative analysis of histone deacetylase inhibitors for the treatment of mycosis fungoides and Sézary syndrome.

Papps T, McCormack C, Buelens O, Van der Weyden C, Twigger R, Campbell BA, Dickinson M, Prince HM. Papps T, et al. Among authors: campbell ba. Br J Dermatol. 2020 Feb;182(2):497-498. doi: 10.1111/bjd.18522. Epub 2019 Oct 13. Br J Dermatol. 2020. PMID: 31512229 No abstract available.

5

A Novel Application of [18F]Fluorothymidine-PET ([18F]FLT-PET) in Clinical Practice to Quantify Regional Bone Marrow Function in a Patient With Treatment-Induced Cytopenias and to Guide "Marrow-Sparing" Radiotherapy.

Campbell BA, Hofman MS, Prince HM. Campbell BA, et al. Clin Nucl Med. 2019 Nov;44(11):e624-e626. doi: 10.1097/RLU.0000000000002785. Clin Nucl Med. 2019. PMID: 31584492

6

Lack of Durable Remission with Conventional-Dose Total Skin Electron Therapy for the Management of Sezary Syndrome and Multiply Relapsed Mycosis Fungoides.

Campbell BA, Ryan G, McCormack C, Tangas E, Bressel M, Twigger R, Buelens O, van der Weyden C, Prince HM. Campbell BA, et al. Cancers (Basel). 2019 Nov 8;11(11):1758. doi: 10.3390/cancers11111758. Cancers (Basel). 2019. PMID: 31717353 Free PMC article.

7

Durable Complete Remission and Long-Term Survival in FDG-PET Staged Patients with Stage III Follicular Lymphoma, Treated with Wide-Field Radiation Therapy.

MacManus MP, Hicks RJ, Bressel M, Campbell BA, Wirth A, Ryan G, Prince HM, Wolf M, Brown R, Seymour JF. MacManus MP, et al. Among authors: campbell ba. Cancers (Basel). 2020 Apr 17;12(4):991. doi: 10.3390/cancers12040991. Cancers (Basel). 2020. PMID: 32316464 Free PMC article.

8

The importance of differentiating between mycosis fungoides with CD30-positive large cell transformation and mycosis fungoides with coexistent primary cutaneous anaplastic large cell lymphoma.

Gao C, McCormack CJ, van der Weyden C, Twigger R, Buelens O, Lade S, Khoo C, Campbell BA, Goh M, McKelvie P, Prince HM. Gao C, et al. Among authors: campbell ba. J Am Acad Dermatol. 2021 Jan;84(1):185-187. doi: 10.1016/j.jaad.2020.04.073. Epub 2020 Apr 22. J Am Acad Dermatol. 2021. PMID: 32334059 No abstract available.

9

Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic.

Di Ciaccio P, McCaughan G, Trotman J, Ho PJ, Cheah CY, Gangatharan S, Wight J, Ku M, Quach H, Gasiorowski R, Polizzotto MN, Prince HM, Mulligan S, Tam CS, Gregory G, Hapgood G, Spencer A, Dickinson M, Latimer M, Johnston A, Armytage T, Lee C, Cochrane T, Berkhahn L, Weinkove R, Doocey R, Harrison SJ, Webber N, Lee HP, Chapman S, Campbell BA, Gibbs SDJ, Hamad N. Di Ciaccio P, et al. Among authors: campbell ba. Intern Med J. 2020 Jun;50(6):667-679. doi: 10.1111/imj.14859. Epub 2020 May 15. Intern Med J. 2020. PMID: 32415723

10

Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma.

Campbell BA, Scarisbrick JJ, Kim YH, Wilcox RA, McCormack C, Prince HM. Campbell BA, et al. Cancers (Basel). 2020 Aug 17;12(8):2311. doi: 10.3390/cancers12082311. Cancers (Basel). 2020. PMID: 32824427 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page